SLE patients also have higher levels of specific soluble mediators such as annexin A5, platelet endothelial cell adhesion molecule (PECAM1) and activated leukocyte cell adhesion molecule (ALCAM). Here, ANXA5 is linked to systemic lupus erythematosus.